Asymchem Laboratories (Tianjin) XSEC:002821 Rapport sur les actions Finances de l'entreprise + 15 Analystes
Asymchem Laboratories (Tianjin) Co., Ltd.
XSEC:002821 Rapport sur les actions
Capitalisation boursière : CN¥31.5b
002821 Aperçu des actions Asymchem Laboratories (Tianjin) Co, Ltd.
Récompenses Analyse des risques Voir tous les contrôles de risques Asymchem Laboratories (Tianjin) Co., Ltd. Concurrents Historique des prix et performances
Résumé des plus hauts, des changements et des baisses de prix pour Asymchem Laboratories (Tianjin) Historique des cours de bourse Prix actuel de l'action CN¥91.25 Plus haut sur 52 semaines CN¥154.45 Plus bas sur 52 semaines CN¥59.55 Bêta 0.16 1Variation sur 1 mois 20.56% Variation sur 3 mois 36.19% Variation sur 1 an -38.61% 3Variation sur 3 ans -69.34% Variation sur 5 ans -9.94% Évolution depuis l'introduction en bourse 77.14%
Nouvelles et mises à jour récentes Asymchem Creates an Artificial Intelligence Platform to Address Key Challenges in Protein Design Nov 07
Third quarter 2024 earnings released: EPS: CN¥0.61 (vs CN¥1.45 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 16% Oct 15
Executive VP & Executive Director recently bought CN¥1.8m worth of stock Oct 15
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 19% Sep 28 Voir plus de mises à jour Asymchem Creates an Artificial Intelligence Platform to Address Key Challenges in Protein Design Nov 07
Third quarter 2024 earnings released: EPS: CN¥0.61 (vs CN¥1.45 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 16% Oct 15
Executive VP & Executive Director recently bought CN¥1.8m worth of stock Oct 15
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 19% Sep 28
CFO, Senior VP & Executive Director recently bought CN¥4.3m worth of stock Sep 18
Second quarter 2024 earnings released: EPS: CN¥0.63 (vs CN¥2.94 in 2Q 2023) Aug 29
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
Dividend of CN¥1.80 announced Jun 27
Asymchem Appoints Cheng Yi Chen as CTO of Small-Molecule Sector Jun 26
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 June 2024 Jun 25 Asymchem Laboratories (Tianjin) Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 Jun 08
Asymchem Appoints Franck Mevellec as Senior Director, Business Development May 30
New major risk - Revenue and earnings growth Apr 01
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Mar 30 Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 06, 2024
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023 Mar 28 Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024. Mar 09
Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Hou Xinyi as an Independent Non-Executive Director, Effective 29 February 2024 Feb 29
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Wang Qingsong as Independent Non-Executive Director and Committees Feb 05
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024 Dec 29
New major risk - Revenue and earnings growth Dec 12
Now 23% undervalued after recent price drop Dec 04
New minor risk - Share price stability Nov 09
Third quarter 2023 earnings released: EPS: CN¥1.45 (vs CN¥2.71 in 3Q 2022) Oct 31
Asymchem Laboratories (Tianjin) Co., Ltd. Appoints Sun Xuejiao as Independent Non-Executive Director Sep 14
New major risk - Revenue and earnings growth Sep 02
Second quarter 2023 earnings released: EPS: CN¥2.94 (vs CN¥3.39 in 2Q 2022) Aug 30
Asymchem Laboratories (Tianjin) Co., Ltd. Implements Final Cash Dividend (A shares) for 2022, Payable on 21 July 2023 Jun 21
Asymchem Laboratories (Tianjin) Co., Ltd. Declares Final Dividend for the Year Ended 31 December 2022. Payable on 21 July 2023 Jun 10
Full year 2022 earnings released: EPS: CN¥9.02 (vs CN¥3.15 in FY 2021) Mar 31 Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2022 Results on Mar 31, 2023
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Resignation of Zhang Kun as an Independent Non-Executive Director Jan 17
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: EPS: CN¥2.71 (vs CN¥0.79 in 3Q 2021) Oct 28
Investor sentiment deteriorated over the past week Sep 17
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) commences an Equity Buyback Plan for CNY 800 million worth of its shares, under the authorization approved on September 2, 2022. Sep 07
Second quarter 2022 earnings released: EPS: CN¥3.38 (vs CN¥0.81 in 2Q 2021) Aug 26
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2022 Results on Aug 25, 2022 Aug 16 Asymchem Laboratories (Tianjin) Co., Ltd. Provides Earnings Guidance for the Period Ended June 30, 2022
Now 27% undervalued after recent price drop Jul 13
Asymchem Laboratories (Tianjin) Co., Ltd. Approves Cash Dividend for the Year 2021 Jun 11
Now 21% undervalued after recent price drop May 26
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 21 July 2022 May 14
Less than half of directors are independent Apr 27
Asymchem Laboratories (Tianjin) Co., Ltd., Annual General Meeting, Jun 09, 2022 Apr 21
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q1, 2022 Results on Apr 20, 2022 Apr 07
Asymchem Laboratories (Tianjin) Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021 Apr 01
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Final Dividend for the Year Ended December 31, 2021 Mar 31
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) entered into an agreement to acquire remaining 81.82% stake in Snapdragon Chemistry, Inc. for $57.9 million. Feb 12
Investor sentiment deteriorated over the past week Feb 12
Asymchem Laboratories (Tianjin) Co., Ltd. Provides Group Earnings Guidance for the Year Ending December 31, 2021 Jan 26
Less than half of directors are independent Jan 21
Asymchem Laboratories (Tianjin) Co., Ltd. has filed an IPO in the amount of HKD 7.550314 billion. Dec 01
Asymchem Laboratories (Tianjin) Co., Ltd. Announces Dividend for 2020 May 21
First quarter 2021 earnings released: EPS CN¥0.64 (vs CN¥0.47 in 1Q 2020) Apr 26
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Fiscal Year 2020 Results on Apr 16, 2021 Mar 09
New 90-day low: CN¥256 Mar 05
Asymchem Laboratories (Tianjin) Co., Ltd. Elects Zhang Ting as Non-Independent Director Feb 11
New 90-day high: CN¥316 Jan 20
New 90-day high: CN¥297 Dec 25
New 90-day high: CN¥288 Nov 09
Asymchem Laboratories (Tianjin) Co., Ltd. to Report Q3, 2020 Results on Oct 24, 2020 Oct 17
New 90-day high: CN¥274 Oct 12
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) signed an equity transfer agreement to acquire Tianjin Guanqin Pharmaceutical Technology Co., Ltd. from Tianjin Shengqin Pharmaceutical Technology Partnership (Limited Partnership) and Liang Qing for CNY 30 million. Sep 10
New 90-day high - CN¥250 Aug 21
Asymchem Laboratories (Tianjin) Co., Ltd. to Report First Half, 2020 Results on Aug 08, 2020 Jul 18 Rendement pour les actionnaires 002821 CN Pharmaceuticals CN Marché 7D 4.8% 4.9% 6.9% 1Y -38.6% 0.03% 10.3%
Voir le rapport complet des actionnaires
Rendement vs Industrie: 002821 a sous-performé le secteur CN Pharmaceuticals qui a rapporté 0 % au cours de l'année écoulée.
Rendement vs marché: 002821 a sous-performé le marché CN qui a rapporté 10.3 % au cours de l'année écoulée.
Volatilité des prix Is 002821's price volatile compared to industry and market? 002821 volatility 002821 Average Weekly Movement 7.8% Pharmaceuticals Industry Average Movement 7.1% Market Average Movement 7.9% 10% most volatile stocks in CN Market 12.2% 10% least volatile stocks in CN Market 5.4%
Cours de l'action stable: 002821 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de 002821 ( 8% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise Asymchem Laboratories (Tianjin) Co., Ltd. fournit des services contractuels de développement et de fabrication axés sur l'innovation et l'application commerciale de technologies pharmaceutiques globales en Chine continentale et à l'échelle internationale. L'entreprise propose des services de recherche et développement et de production aux entreprises pharmaceutiques et biotechnologiques. Ses solutions s'étendent du stade clinique précoce au stade commercial, y compris la recherche et le développement, et la production cGMP d'intermédiaires avancés, d'ingrédients pharmaceutiques actifs et de formulations, ainsi que des services de recherche clinique.
Afficher plus Asymchem Laboratories (Tianjin) Co., Ltd. Résumé des fondamentaux Comment les bénéfices et les revenus de Asymchem Laboratories (Tianjin) se comparent-ils à sa capitalisation boursière ? 002821 statistiques fondamentales Capitalisation boursière CN¥31.45b Bénéfices(TTM) CN¥769.03m Recettes(TTM ) CN¥5.57b
Bénéfices et recettes Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM) 002821 compte de résultat (TTM ) Recettes CN¥5.57b Coût des recettes CN¥3.24b Marge brute CN¥2.33b Autres dépenses CN¥1.56b Les revenus CN¥769.03m
Derniers bénéfices déclarés
Sep 30, 2024
Prochaine date de publication des résultats
s/o
Résultat par action (EPS) 2.17 Marge brute 41.86% Marge bénéficiaire nette 13.80% Ratio dettes/capitaux propres 0%
Quelles ont été les performances à long terme de 002821?
Voir les performances historiques et les comparaisons Dividendes
2.0% Rendement actuel des dividendes
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
